movement disorders:孤立的快速眼动睡眠,语言异常或可提示认知障碍

2022-07-13 Freeman MedSci原创

语言学特征可能为检测iRBD受试者中由前驱神经变性引起的认知能力下降提供了可靠的自动方法

目前正在开发帕金森病(PD)等神经退行性疾病。因为引入疾病修正治疗的最佳时间段是神经退行性疾病的前驱阶段,所以找到这一疾病阶段的诊断和进展性生物标志物至关重要。孤立的快速眼动睡眠行为障碍(iRBD)是一种寄生性失眠症,其特点是与快速眼动睡眠期间肌肉失张力有关的梦境行动行为。

图1: 论文封面图

多项研究认为,iRBD是突触蛋白病的前驱标志,有70%至80%的风险发展为明显的神经退行性疾病,特别是PD或路易体痴呆(DLB)。

iRBD患者认知能力下降的模式和严重程度可以预测突触核蛋白病的亚型。认知恶化更能预测DLB的发展,而在那些将发展为PD或保持无突触蛋白病的iRBD患者中,通常会观察到认知性能的未改变。

有趣的是,认知能力的细微缺陷甚至影响到那些不符合轻度认知障碍(MCI)标准的iRBD患者。对语言功能(MCI的一个核心认知领域)的调查和细微的认知衰退研究提供了关于几种神经退行性疾病中认知改变的独特模式的宝贵信息。

事实上,在PD和其他基底神经节疾病中普遍观察到语言异常,如句法复杂性受限和词汇-语义理解能力。到目前为止,还没有研究对iRBD患者潜在的前驱语言障碍进行研究。

如今,数字技术的进步为语言处理提供了新的可能性。自动语音识别(ASR)和自然语言处理(NLP)用于分析和分类语言,在智能手机等广泛的设备上广泛使用。因此,基于自发语音的生物标志物可能大大受益于在实验室环境之外获得的自动数据分析,并有可能适用于大量人群。然而,突触神经病患者不仅可能出现认知上的改变,还可能出现运动性言语障碍,这两者都可能给自动识别和NLP技术带来困难,无法正确转录和注释语音。此外,用于话语分析的各种自发话语可能给MCI患者带来进一步的困难。

藉此,捷克布拉格科技大学的Martin Šubert等人,评估在不同类型的自发话语中检查的语言障碍,是否能在iRBD患者和有或没有MCI的PD患者中发现。还探索是否可以通过使用现有的ASR和NLP技术,以完全自动化的方式进行前驱和表现的突触神经病的话语分析。

他们招募了139名捷克本地参与者,包括40名无MCI的iRBD和14名有MCI的iRBD,与40名无MCI的PD、15名有MCI的PD和30名健康对照对象进行比较。

对自发的话语和故事叙述进行了转录和语言学上的注释。进行了定量分析,计算了三种语言学特征。人工注释与全自动注释进行了比较。

 

图2:论文结果图

他们发现: 与对照组相比,iRBD患者的内容密度较差,反映了内容词和修饰词的减少。患有MCI的PD和iRBD亚组都表现出较少出现独特的词和较多的n-grams重复,表明词汇的丰富性较差。

自发话语任务显示了没有MCI的iRBD的语言障碍,曲线下面积为0.72,而故事叙述任务更好地反映了MCI的存在,将PD和iRBD亚组的MCI与对照组区分开,曲线下面积高达0.81。

此外,手动和自动计算的结果之间有很强的相关性。

他们发现:语言学特征可能为检测iRBD受试者中由前驱神经变性引起的认知能力下降提供了可靠的自动方法,为未来的治疗试验提供了关键结果。

 

原文出处:
Šubert M, Šimek M, Novotný M, et al. Linguistic Abnormalities in Isolated Rapid Eye Movement Sleep Behavior Disorder. _Movement Disorders_. Published online July 7, 2022:mds.29140. doi:[10.1002/mds.29140](https://doi.org/10.1002/mds.29140)

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-12-10 cmsvly
  3. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-12-10 anminleiryan
  4. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-14 yangjxjc
  8. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 桐梓坡凯

    踩一踩留个脚印,后面看

    0

相关资讯

Movement disorders:帕金森病:黑质中的铁沉积,如何随时间变化?

在开始使用多巴胺能药物治疗之前,黑质铁较低,然后在整个疾病过程中不断增加,直到晚期达到平稳

Cell:徐浩新/胡美钦/李平/王策等揭示帕金森病发病风险的新机制

该研究开辟了溶酶体 pH 调节的新方向,首次鉴定出溶酶体膜上的氢离子通道:TMEM175 是一种新型的氢离子激活的氢离子通道。

Movement disorders-帕金森病伴肌张力障碍与否,皮层和下丘脑有何改变?

运动皮层和STN场电位的频谱功率在重复肢体运动时有明显的不同。

Movement disorders:帕金森患者,糖尿病可加速其进展

T2DM与帕金森病的疾病进展速度有关,突出了这两种疾病之间的互动。

Movement disorders 同济大学;帕金森病:短链脂肪酸减少,或因肠-血屏障受损

PD患者的粪便和血浆SCFAs的改变与GBB受损有关,并可能因便秘而加重。

拓展阅读

AAN 2024大会盛况回顾,带您领略神经病学新高度!

作为神经科医生,您一定对AAN 2024年大会充满期待。我们为您精心整理了大会内容解读,包括最新研究成果、临床实践经验和未来发展趋势等,让您足不出户就能领略到大会的精彩盛况!点击立即查看别错过!

AAN 2024:突触核蛋白皮肤活检在帕金森病的初步诊断的临床实践

帕金森病早期准确诊断是一项尚未满足的重大需求,这对于早期干预和预后改善有着重要的影响。

Nature Medicine:重塑帕金森病治疗前景:Prasinezumab在早期帕金森病快速进展亚型中的疗效分析

文章探讨了Prasinezumab这种单克隆抗体在早期帕金森病中的潜在的治疗作用。

【帕金森病专题分享】探索帕金森病进展及诊疗全攻略

帕金森病日来临之际,我们特别推出了帕金森病专题系列文章。无论你是初入此领域的新手,还是经验丰富的专家,这里都有你需要的知识和信息。点击立即阅读,共同提升帕金森病诊疗水平!

话题:帕金森病的真相你了解多少?

我们欢迎各位老师,学者们在下方评论区共同探讨帕金森病的各个方面,包括但不限于:帕金森病的介绍、早期症状、体征、预防等都可一起分享出来。

好文推荐 | 帕金森病睡眠障碍结构特征及其影响因素的临床研究

探讨帕金森病(PD)患者睡眠障碍的发生率、睡眠结构特征、影响因素。

2024 NICE 诊断指南:帕金森病远程监测设备 [DG51]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-25

2023 NICE 技术鉴定指南:左旋多巴/卡比多巴组合治疗伴有运动症状的晚期帕金森病[TA934]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-11-29

帕金森病患者睡眠障碍评估与护理干预的最佳证据总结

浙江中医药大学护理学院 · 2023-08-10

早中期帕金森病患者运动管理的最佳证据总结

山东第一医科大学附属省立医院老年神经内科 · 2023-05-10